CARRii (Centre for Applied Respiratory Research & Innovation) is a UK research centre dedicated to enhancing lung health by supporting the implementation of high-quality research into clinical practice, with the aim of reducing hospital admissions, easing NHS winter healthcare pressures, and improving patient outcomes.

Anaphylaxis is a time-critical emergency. Prompt intramuscular (IM) adrenaline remains the first-line treatment, rapidly reversing airway oedema, vasodilatation and bronchospasm (MHRA, 2023). However, barriers such as fear of needles, incorrect injection technique or hesitancy are well documented and may delay or impair its administration. In real-world settings, these human factors can influence outcomes as much as the pharmacotherapy itself.

Healthcare professionals who are passionate about improving respiratory care are invited to attend the PCRS Respiratory Conference from 24th to 26th of September 2026 at the Telford International Centre. This is the UK’s leading respiratory conference for clinicians working in primary, community and integrated care.

This edition of PCRU follows an exciting few months at the Primary Care Respiratory Society (PCRS). As part of the Respiratory Transformation Partnership (RTP), PCRS is supporting the development of new primary care referral pathways and resources for chronic cough, breathlessness and sleep services, ensuring these are aligned with primary care systems and supporting clinicians with their everyday practice in these areas. 

The Primary Care Respiratory Society UK (PCRS) is increasingly alarmed by the widespread and accelerating loss of respiratory leadership, expertise and strategic capacity across Integrated Care Boards (ICBs), regional NHS structures, and Primary Care Networks (PCNs). This erosion is occurring at the very time when national policy places unprecedented expectations on primary care and systems to transform and deliver high-quality respiratory care closer to home.

With the new maintenance and reliever therapy (MART) license for children, this simple guide provides information and guidance on introducing children of 5-11 years of age safely and effectively to a MART regimen. It covers:

The PCRS blueprint for Neighbourhood Health in COPD outlines how Neighbourhood Health models could organise COPD care around integrated local services. It proposes clear points of contact, population health management, coordinated, collaborative and personalised care planning and access to diagnostics, community respiratory teams and multidisciplinary support. It advocates for holistic, patient-centred care, as well as appropriate funding, diagnostic capacity and strong collaboration between health, social care and community partners.

The Asthma Slide Rule supports implementation of the 2024 BTS/NICE/SIGN asthma guideline, greener respiratory healthcare and is a gateway to establishing short-acting beta2-agonist (SABA) free treatment pathways. It should be used:

The Primary Care Respiratory Society (PCRS) recognises that short-term respiratory admissions can be reduced but not always entirely avoided. These admissions occur when patients require hospital-based stabilisation, diagnosis or treatment which is not otherwise available to them in primary care. In line with the 10-Year health plan for England: Fit for the future, PCRS supports patient care in the community and care delivered closer to home.